Prevention of Chemotherapy-Induced Hemorrhagic Cystitis
Chemotherapy-induced hemorrhagic cystitis (HC) is a serious urological complication predominantly associated with the use of alkylating agents such as cyclophosphamide and ifosfamide. It manifests as bladder mucosal bleeding, dysuria, hematuria, and potential long-term bladder dysfunction. Prevention is imperative to avoid treatment delays, hospitalizations, or severe morbidity. This comprehensive clinical guide outlines robust, evidence-backed strategies for